. "6"^^ . . . "3" . "4"^^ . . . "2"^^ . . . "RIV/00023752:_____/11:00001183!RIV12-MZ0-00023752" . "Barto\u0161, Ale\u0161" . "[9FB2C11CA9B5]" . . . "Alzheimerova nemoc a m\u00EDrn\u00E1 kognitivn\u00ED porucha: diagnostika a l\u00E9\u010Dba"@cs . "Dole\u017Eil, David" . . . "Alzheimerova nemoc a m\u00EDrn\u00E1 kognitivn\u00ED porucha: diagnostika a l\u00E9\u010Dba" . "\u010Cechov\u00E1, Linda" . . . "Alzheimer's disease; mild cognitive impairment; dementia; diagnostics; biomarkers; therapy"@en . "http://www.neurologiepropraxi.cz/pdfs/neu/2011/03/08.pdf" . . "I, P(GD309/09/H072), P(KAN200520701), P(NS10369)" . "\u0158\u00EDpov\u00E1, Daniela" . . "185328" . "RIV/00023752:_____/11:00001183" . "Alzheimerova nemoc a m\u00EDrn\u00E1 kognitivn\u00ED porucha: diagnostika a l\u00E9\u010Dba"@cs . "Neurologie pro praxi" . . "CZ - \u010Cesk\u00E1 republika" . "Early recognition of the dementia syndrome is the most important part in the diagnostics of Alzheimer's disease. It is followed by determination of Alzheimer's disease as the most likely cause of it. A clinical transitional state between the normal ageing and dementia is referred to as mild cognitive impairment. The auxiliary diagnostic methods are not only used to rule out other causes of dementia, but they can directly support the diagnosis of Alzheimer's disease. The clinical trials have proved that current drugs slow the progression of the disease. We can use acetylcholinesterase inhibitors for treatment of mild to moderate Alzheimer's disease, whereas severe stages of the disease are treated by memantin - NMDA receptor partial antagonist."@en . "12" . . "1213-1814" . "Alzheimerova nemoc a m\u00EDrn\u00E1 kognitivn\u00ED porucha: diagnostika a l\u00E9\u010Dba" . "V diagnostice Alzheimerovy nemoci je z\u00E1sadn\u00ED v\u010Dasn\u00E9 rozpozn\u00E1n\u00ED p\u0159\u00EDtomnosti syndromu demence, n\u00E1sledov\u00E1no ur\u010Den\u00EDm Alzheimerovy nemoci jako jeho nejpravd\u011Bpodobn\u011Bj\u0161\u00ED p\u0159\u00ED\u010Diny. P\u0159echodn\u00FDm stavem mezi norm\u00E1ln\u00EDm st\u00E1rnut\u00EDm a demenc\u00ED je m\u00EDrn\u00E1 kognitivn\u00ED porucha. Pomocn\u00E9 vy\u0161et\u0159ovac\u00ED metody ji\u017E neslou\u017E\u00ED pouze k vylou\u010Den\u00ED jin\u00FDch p\u0159\u00ED\u010Din demence, ale mohou p\u0159\u00EDmo podpo\u0159it diagn\u00F3zu Alzheimerovy nemoci. Klinick\u00FDmi studiemi je prok\u00E1z\u00E1n efekt pou\u017E\u00EDvan\u00FDch l\u00E9k\u016F na zpomalen\u00ED pr\u016Fb\u011Bhu nemoci. Pro l\u00E9\u010Dbu lehk\u00E9 a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00E9 formy Alzheimerovy nemoci jsou k dispozici inhibitory acetylcholinester\u00E1zy, pro t\u011B\u017Ekou formu parci\u00E1ln\u00ED antagonista NMDA receptor\u016F - memantin." . . "Alzheimer\u00B4s disease and mild cognitive impairment: diagnosis and treatment"@en . . "Alzheimer\u00B4s disease and mild cognitive impairment: diagnosis and treatment"@en . . . . . "V diagnostice Alzheimerovy nemoci je z\u00E1sadn\u00ED v\u010Dasn\u00E9 rozpozn\u00E1n\u00ED p\u0159\u00EDtomnosti syndromu demence, n\u00E1sledov\u00E1no ur\u010Den\u00EDm Alzheimerovy nemoci jako jeho nejpravd\u011Bpodobn\u011Bj\u0161\u00ED p\u0159\u00ED\u010Diny. P\u0159echodn\u00FDm stavem mezi norm\u00E1ln\u00EDm st\u00E1rnut\u00EDm a demenc\u00ED je m\u00EDrn\u00E1 kognitivn\u00ED porucha. Pomocn\u00E9 vy\u0161et\u0159ovac\u00ED metody ji\u017E neslou\u017E\u00ED pouze k vylou\u010Den\u00ED jin\u00FDch p\u0159\u00ED\u010Din demence, ale mohou p\u0159\u00EDmo podpo\u0159it diagn\u00F3zu Alzheimerovy nemoci. Klinick\u00FDmi studiemi je prok\u00E1z\u00E1n efekt pou\u017E\u00EDvan\u00FDch l\u00E9k\u016F na zpomalen\u00ED pr\u016Fb\u011Bhu nemoci. Pro l\u00E9\u010Dbu lehk\u00E9 a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00E9 formy Alzheimerovy nemoci jsou k dispozici inhibitory acetylcholinester\u00E1zy, pro t\u011B\u017Ekou formu parci\u00E1ln\u00ED antagonista NMDA receptor\u016F - memantin."@cs .